Value stocks typically trade at discounts to the broader market, offering patient investors the opportunity to buy businesses when they’re out of favor. The key risk, however, is that these stocks are usually cheap for a reason – five cents for a piece of fruit may seem like a great deal until you find out it’s rotten.
This distinction between true value and value traps can challenge even the most skilled investors. Luckily for you, we started StockStory to help you uncover exceptional companies. That said, here is one value stock trading at a big discount to its intrinsic value and two with little support.
Two Value Stocks to Sell:
Amneal (AMRX)
Forward P/E Ratio: 12.9x
Founded in 2002 and growing into one of America's largest generic drug producers, Amneal Pharmaceuticals (NASDAQ: AMRX) develops, manufactures, and distributes generic medicines, specialty branded drugs, biosimilars, and injectable products for the U.S. healthcare market.
Why Are We Cautious About AMRX?
- Estimated sales growth of 2.4% for the next 12 months implies demand will slow from its two-year trend
- Low returns on capital reflect management’s struggle to allocate funds effectively
Amneal’s stock price of $12.75 implies a valuation ratio of 12.9x forward P/E. If you’re considering AMRX for your portfolio, see our FREE research report to learn more.
WesBanco (WSBC)
Forward P/B Ratio: 0.8x
Tracing its roots back to 1870 in West Virginia, WesBanco (NASDAQ: WSBC) is a bank holding company that provides retail and commercial banking, trust services, insurance, and investment products through its subsidiaries across several Midwestern and Mid-Atlantic states.
Why Does WSBC Give Us Pause?
- Net interest margin of 3.4% is well below other banks, signaling its loans aren’t very profitable
- Products and services are facing profitability challenges during this cycle, as seen in its flat tangible book value per share over the last five years
- Underwhelming 6.8% return on equity reflects management’s difficulties in finding profitable growth opportunities
WesBanco is trading at $34.47 per share, or 0.8x forward P/B. Read our free research report to see why you should think twice about including WSBC in your portfolio.
One Value Stock to Watch:
Concentrix (CNXC)
Forward P/E Ratio: 2x
With a team of approximately 450,000 employees across 75 countries, Concentrix (NASDAQ: CNXC) designs and delivers customer experience solutions that help global brands manage their customer interactions across digital channels and contact centers.
Why Are We Fans of CNXC?
- Impressive 15.3% annual revenue growth over the last five years indicates it’s winning market share this cycle
- $9.95 billion in revenue allows it to spread its fixed costs across a wider base
At $24.56 per share, Concentrix trades at 2x forward P/E. Is now the right time to buy? Find out in our full research report, it’s free.
Stocks We Like Even More
ONE MORE THING: Top 5 Growth Stocks. The biggest stock winners almost always had one thing in common before they ran. Revenue growing like crazy. Meta. CrowdStrike. Broadcom. Our AI flagged all three. They returned 315%, 314%, and 455%, respectively.
Find out which 5 stocks it's flagging for this month - FREE. Get Our Top 5 Growth Stocks for Free HERE.
Stocks that made our list in 2020 include now familiar names such as Nvidia (+1,326% between June 2020 and June 2025) as well as under-the-radar businesses like the once-small-cap company Comfort Systems (+782% five-year return). Find your next big winner with StockStory today.
